Approval · Notice of Compliance 18817 · 2016
NUWIQ: Notice of Compliance 18817
Issued December 28, 2016
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 18817
- Date
- December 28, 2016
- Company
- Octapharma Pharmazeutika Produktionsges M B HVienna, Vienne, Austria
- Product type
- Biologic
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- Manufacturing scale-up
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| NUWIQ | Not yet assigned | — |
Medicinal ingredients
- SIMOCTOCOG ALFA 250 UNIT per VIAL
- SIMOCTOCOG ALFA 500 UNIT per VIAL
- SIMOCTOCOG ALFA 1,000 UNIT per VIAL
- SIMOCTOCOG ALFA 2,000 UNIT per VIAL